CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 664944-665109 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T26890","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The most prevalent symptoms in CRScNP were: nasal purulence/discharge (97.6%)\u003ehyposmia/anosmia (85.4%)\u003efacial pain/pressure/headache (82.9%)\u003enasal obstruction (61%)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T295","span":{"begin":0,"end":165},"obj":"Sentence"}],"text":"The most prevalent symptoms in CRScNP were: nasal purulence/discharge (97.6%)\u003ehyposmia/anosmia (85.4%)\u003efacial pain/pressure/headache (82.9%)\u003enasal obstruction (61%)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6170","span":{"begin":87,"end":94},"obj":"Disease"}],"attributes":[{"id":"A6170","pred":"mondo_id","subj":"T6170","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"}],"text":"The most prevalent symptoms in CRScNP were: nasal purulence/discharge (97.6%)\u003ehyposmia/anosmia (85.4%)\u003efacial pain/pressure/headache (82.9%)\u003enasal obstruction (61%)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T3311","span":{"begin":78,"end":86},"obj":"Phenotype"},{"id":"T3312","span":{"begin":87,"end":94},"obj":"Phenotype"},{"id":"T3313","span":{"begin":110,"end":114},"obj":"Phenotype"},{"id":"T3314","span":{"begin":124,"end":132},"obj":"Phenotype"},{"id":"T3315","span":{"begin":141,"end":158},"obj":"Phenotype"}],"attributes":[{"id":"A3311","pred":"hp_id","subj":"T3311","obj":"http://purl.obolibrary.org/obo/HP_0004409"},{"id":"A3312","pred":"hp_id","subj":"T3312","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A3313","pred":"hp_id","subj":"T3313","obj":"http://purl.obolibrary.org/obo/HP_0012531"},{"id":"A3314","pred":"hp_id","subj":"T3314","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A3315","pred":"hp_id","subj":"T3315","obj":"http://purl.obolibrary.org/obo/HP_0001742"}],"text":"The most prevalent symptoms in CRScNP were: nasal purulence/discharge (97.6%)\u003ehyposmia/anosmia (85.4%)\u003efacial pain/pressure/headache (82.9%)\u003enasal obstruction (61%)."}